Network Biology: Current Status, Applications, Challenges, and Future Prospects
MedComm · 2026-10 · 7 (10)
DOI: 10.1002/mco2.71065 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift MedComm, online erschienen am 13.10.2026. Verfasst von Xinmeng Li und 7 weiteren Autor:innen. Beteiligte Einrichtung: Aging Decoding and Regeneration Institute, School of Life Sciences Zhengzhou University Zhengzhou China. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 245 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Henan Province.
Abstract (Originalsprache)
Network biology provides a systems‐level framework for understanding how interactions among molecular components, cells, microbial communities, tissues, and organs generate biological function and disease phenotypes. Recent advances in multiomics, single‐cell and spatial profiling, network inference, organoid and organ‐on‐chip technologies, computational modeling, and artificial intelligence have shifted the field from static molecular maps toward dynamic, multiscale, and predictive network models. Major branches include molecular interaction networks, intracellular regulatory networks, single‐cell and multicellular networks, microbial networks, disease networks, and interorgan interaction networks. Experimental and computational approaches are compared with respect to network reconstruction, causal validation, and cross‐scale integration. Biomedical applications span disease classification, biomarker discovery, therapeutic‐target identification, drug–response prediction, regenerative medicine, and precision healthcare. Particular emphasis is placed on interorgan interaction networks, in which carrier, route, range, timescale, recipient specificity, directionality, and feedback are treated as distinct mechanistic dimensions while mechanistic confidence is distinguished from translational maturity. Persistent challenges include incomplete context‐specific network reconstruction, uncertain causal directionality, limited cross‐scale integration, model interpretability, and insufficient clinical validation. Further progress will depend on integrating longitudinal and perturbation‐resolved measurements with human‐relevant experimental systems and multiscale computational models that quantify uncertainty and support prospective validation of patient‐specific predictions.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Aging Decoding and Regeneration Institute, School of Life Sciences Zhengzhou University Zhengzhou China.
- The First Affiliated Hospital of Henan University Kaifeng China.
- NHC Key Laboratory of Prevention and Treatment of Central Asia High Incidence Diseases, Key Laboratory of Xinjiang Endemic and Ethnic Diseases Shihezi University School of Medicine Shihezi China.
ORCID-Profile: Zhengwei Li
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Henan Province
Zitieren
APA
Li, X., Zhang, L., Ding, Y., Li, K., Chang, S., Pei, L., Li, Z., & Chen, Z. (2026). Network Biology: Current Status, Applications, Challenges, and Future Prospects. MedComm, 7(10). https://doi.org/10.1002/mco2.71065
Vancouver
Li X, Zhang L, Ding Y, Li K, Chang S, Pei L, et al. Network Biology: Current Status, Applications, Challenges, and Future Prospects. MedComm. 2026;7(10). doi:10.1002/mco2.71065
BibTeX
@article{Li2026,
author = {Li, Xinmeng and Zhang, Laizhong and Ding, Yawen and Li, Kai and Chang, Shiyuan and Pei, Linsen and Li, Zhengwei and Chen, Zhenzhen},
title = {Network Biology: Current Status, Applications, Challenges, and Future Prospects},
journal = {MedComm},
year = {2026},
volume = {7},
number = {10},
doi = {10.1002/mco2.71065}
}
EUVIMED